| Authors: |
Fix SM; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Forget MA; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sakellariou-Thompson D; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang Y; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Griffiths TM; Biologics Development, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lee M; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Haymaker CL; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Dominguez AL; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Basar R; Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Reyes C; Cell Biology R&D, Thermo Fisher Scientific, Carlsbad, California, USA., Kumar S; Cell Biology R&D, Thermo Fisher Scientific, Carlsbad, California, USA., Meyer LA; Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hwu P; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Patrick.Hwu@moffitt.org., Bernatchez C; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jazaeri AA; Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
